294 related articles for article (PubMed ID: 15374956)
1. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.
Bassett E; King NM; Bryant MF; Hector S; Pendyala L; Chaney SG; Cordeiro-Stone M
Cancer Res; 2004 Sep; 64(18):6469-75. PubMed ID: 15374956
[TBL] [Abstract][Full Text] [Related]
2. Overproduction of DNA polymerase eta does not raise the spontaneous mutation rate in diploid human fibroblasts.
King NM; Nikolaishvili-Feinberg N; Bryant MF; Luche DD; Heffernan TP; Simpson DA; Hanaoka F; Kaufmann WK; Cordeiro-Stone M
DNA Repair (Amst); 2005 Jun; 4(6):714-24. PubMed ID: 15886068
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
Bassett E; Vaisman A; Havener JM; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2003 Dec; 42(48):14197-206. PubMed ID: 14640687
[TBL] [Abstract][Full Text] [Related]
4. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.
Vaisman A; Lim SE; Patrick SM; Copeland WC; Hinkle DC; Turchi JJ; Chaney SG
Biochemistry; 1999 Aug; 38(34):11026-39. PubMed ID: 10460158
[TBL] [Abstract][Full Text] [Related]
5. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
Chaney SG; Campbell SL; Bassett E; Wu Y
Crit Rev Oncol Hematol; 2005 Jan; 53(1):3-11. PubMed ID: 15607931
[TBL] [Abstract][Full Text] [Related]
6. Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt gene of mouse fibroblasts expressing antisense RNA to DNA polymerase zeta.
Diaz M; Watson NB; Turkington G; Verkoczy LK; Klinman NR; McGregor WG
Mol Cancer Res; 2003 Sep; 1(11):836-47. PubMed ID: 14517346
[TBL] [Abstract][Full Text] [Related]
7. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
Vaisman A; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2000 Apr; 39(16):4575-80. PubMed ID: 10769112
[TBL] [Abstract][Full Text] [Related]
8. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.
Bassett E; Vaisman A; Tropea KA; McCall CM; Masutani C; Hanaoka F; Chaney SG
DNA Repair (Amst); 2002 Dec; 1(12):1003-16. PubMed ID: 12531010
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus mediated transduction of the human DNA polymerase eta cDNA.
Lima-Bessa KM; Chiganças V; Stary A; Kannouche P; Sarasin A; Armelini MG; de Fátima Jacysyn J; Amarante-Mendes GP; Cordeiro-Stone M; Cleaver JE; Menck CF
DNA Repair (Amst); 2006 Aug; 5(8):925-34. PubMed ID: 16798111
[TBL] [Abstract][Full Text] [Related]
10. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I
Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cells.
Silva MJ; Costa P; Dias A; Valente M; Louro H; Boavida MG
Environ Mol Mutagen; 2005 Aug; 46(2):104-15. PubMed ID: 15887215
[TBL] [Abstract][Full Text] [Related]
12. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.
Albertella MR; Green CM; Lehmann AR; O'Connor MJ
Cancer Res; 2005 Nov; 65(21):9799-806. PubMed ID: 16267001
[TBL] [Abstract][Full Text] [Related]
13. DNA polymerase eta, a key protein in translesion synthesis in human cells.
Cruet-Hennequart S; Gallagher K; Sokòl AM; Villalan S; Prendergast AM; Carty MP
Subcell Biochem; 2010; 50():189-209. PubMed ID: 20012583
[TBL] [Abstract][Full Text] [Related]
14. Protein interactions with platinum-DNA adducts: from structure to function.
Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
[TBL] [Abstract][Full Text] [Related]
15. The role of DNA polymerase eta in UV mutational spectra.
Choi JH; Pfeifer GP
DNA Repair (Amst); 2005 Feb; 4(2):211-20. PubMed ID: 15590329
[TBL] [Abstract][Full Text] [Related]
16. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts.
Vaisman A; Varchenko M; Umar A; Kunkel TA; Risinger JI; Barrett JC; Hamilton TC; Chaney SG
Cancer Res; 1998 Aug; 58(16):3579-85. PubMed ID: 9721864
[TBL] [Abstract][Full Text] [Related]
17. Adduct size limits efficient and error-free bypass across bulky N2-guanine DNA lesions by human DNA polymerase eta.
Choi JY; Guengerich FP
J Mol Biol; 2005 Sep; 352(1):72-90. PubMed ID: 16061253
[TBL] [Abstract][Full Text] [Related]
18. Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice.
Lin Q; Clark AB; McCulloch SD; Yuan T; Bronson RT; Kunkel TA; Kucherlapati R
Cancer Res; 2006 Jan; 66(1):87-94. PubMed ID: 16397220
[TBL] [Abstract][Full Text] [Related]
19. Specificity of platinum-DNA adduct repair.
Chaney SG; Vaisman A
J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
[TBL] [Abstract][Full Text] [Related]
20. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta.
Alt A; Lammens K; Chiocchini C; Lammens A; Pieck JC; Kuch D; Hopfner KP; Carell T
Science; 2007 Nov; 318(5852):967-70. PubMed ID: 17991862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
